Your browser doesn't support javascript.
loading
ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle.
Bousquet, J; Hellings, P W; Agache, I; Bedbrook, A; Bachert, C; Bergmann, K C; Bewick, M; Bindslev-Jensen, C; Bosnic-Anticevitch, S; Bucca, C; Caimmi, D P; Camargos, P A M; Canonica, G W; Casale, T; Chavannes, N H; Cruz, A A; De Carlo, G; Dahl, R; Demoly, P; Devillier, P; Fonseca, J; Fokkens, W J; Guldemond, N A; Haahtela, T; Illario, M; Just, J; Keil, T; Klimek, L; Kuna, P; Larenas-Linnemann, D; Morais-Almeida, M; Mullol, J; Murray, R; Naclerio, R; O'Hehir, R E; Papadopoulos, N G; Pawankar, R; Potter, P; Ryan, D; Samolinski, B; Schunemann, H J; Sheikh, A; Simons, F E R; Stellato, C; Todo-Bom, A; Tomazic, P V; Valiulis, A; Valovirta, E; Ventura, M T; Wickman, M.
Afiliação
  • Bousquet J; Montpellier University Hospital, Montpellier, France ; MACVIA-France, Contre les MAladies Chroniques pour un VIeillissement Actif en France, European Innovation Partnership on Active and Healthy Ageing Reference Site, Montpellier, France ; INSERM, U1168, Ageing and Chronic Diseases Epidemiological a
  • Hellings PW; Laboratory of Clinical Immunology, Department of Microbiology and Immunology, KU Leuven, Louvain, Belgium.
  • Agache I; Transylvania University Brasov, Brasov, Romania.
  • Bedbrook A; MACVIA-France, Contre les MAladies Chroniques pour un VIeillissement Actif en France, European Innovation Partnership on Active and Healthy Ageing Reference Site, Montpellier, France.
  • Bachert C; Upper Airways Research Laboratory, ENT Department, Ghent University Hospital, Ghent, Belgium.
  • Bergmann KC; Allergy-Centre-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Berlin, Germany ; Global Allergy and Asthma European Network (GA²LEN), Berlin, Germany.
  • Bewick M; iQ4U Consultants Ltd, London, UK.
  • Bindslev-Jensen C; Department of Dermatology and Allergy Centre, Odense University Hospital, Odense, Denmark.
  • Bosnic-Anticevitch S; Woolcock Institute of Medical Research, University of Sydney and Sydney Local Health District, Glebe, NSW Australia.
  • Bucca C; University Pneumology Unit-AOU Molinette, Hospital City of Health and Science of Torino, Turin, Italy.
  • Caimmi DP; Department of Respiratory Diseases, Montpellier University Hospital, Montpellier, France.
  • Camargos PA; Department of Pediatrics, Medical School, Federal University of Minas Gerais, Belo Horizonte, Brazil.
  • Canonica GW; Asthma and Allergy Clinic, Humanitas University, Rozzano, Milan, Italy.
  • Casale T; Division of Allergy/Immunology, University of South Florida, Tampa, FL USA.
  • Chavannes NH; Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, The Netherlands.
  • Cruz AA; ProAR - Nucleo de Excelencia em Asma, Federal University of Bahia, Salvador, Brazil ; GARD Executive Committee, Salvador, Bahia Brazil.
  • De Carlo G; EFA European Federation of Allergy and Airways Diseases Patients' Associations, Brussels, Belgium.
  • Dahl R; ProAR - Nucleo de Excelencia em Asma, Federal University of Bahia, Salvador, Brazil.
  • Demoly P; Department of Respiratory Diseases, Montpellier University Hospital, Montpellier, France ; EPAR U707 INSERM, Paris, France ; EPAR UMR-S UPMC, Paris VI, Paris, France.
  • Devillier P; Laboratoire de Pharmacologie Respiratoire UPRES EA220, Hôpital Foch, Suresnes Université Versailles, Saint-Quentin, France.
  • Fonseca J; Center for Research in Health Technologies and Information Systems - CINTESIS, Universidade do Porto, Porto, Portugal ; Allergy Unit, Instituto CUF Porto e Hospital CUF Porto, Porto, Portugal ; Health Information and Decision Sciences Department - CIDES, Faculdade de Medicina, Universidade do Porto,
  • Fokkens WJ; Department of Otorhinolaryngology, Academic Medical Centre, Amsterdam, The Netherlands.
  • Guldemond NA; Institute of Health Policy and Management IBMG, Erasmus University, Rotterdam, The Netherlands.
  • Haahtela T; Skin and Allergy Hospital, Helsinki University Hospital, Helsinki, Finland.
  • Illario M; Federico II University Hospital Naples (R&D and DISMET), Naples, Italy.
  • Just J; Allergology Department, Centre de l'Asthme et des Allergies, Hôpital d'Enfants Armand-Trousseau (APHP), Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Equipe EPAR, 75013 Paris, France.
  • Keil T; Institute of Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin, Berlin, Germany ; Institute for Clinical Epidemiology and Biometry, University of Wuerzburg, Würzburg, Germany.
  • Klimek L; Center for Rhinology and Allergology, Wiesbaden, Germany.
  • Kuna P; Division of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Lodz, Poland.
  • Larenas-Linnemann D; Clínica de Alergia, Asma y Pediatría, Hospital Médica Sur, Mexico City, Mexico.
  • Morais-Almeida M; Allergy and Clinical Immunology Department, Hospital CUF-Descobertas, Lisbon, Portugal.
  • Mullol J; ENT Department, Hospital Clinic, Clinical and Experimental Respiratory Immunoallergy, IDIBAPS, CIBERES, Universitat de Barcelona, Barcelona, Catalonia Spain.
  • Murray R; MedScript Ltd, Dundalk, County Louth, Ireland.
  • Naclerio R; Section of Otolaryngology-Head and Neck Surgery, The University of Chicago Medical Center and The Pritzker School of Medicine, The University of Chicago, Chicago, IL USA.
  • O'Hehir RE; Department of Allergy, Immunology and Respiratory Medicine, Alfred Hospital and Central Clinical School, Monash University, Melbourne, VIC Australia ; Department of Immunology, Monash University, Melbourne, VIC Australia.
  • Papadopoulos NG; Center for Pediatrics and Child Health, Institute of Human Development, Royal Manchester Children's Hospital, University of Manchester, Manchester, UK ; Allergy Department, 2nd Pediatric Clinic, Athens General Children's Hospital "P&A Kyriakou", University of Athens, Athens, Greece.
  • Pawankar R; Department of Pediatrics, Nippon Medical School, Tokyo, Japan.
  • Potter P; Allergy Diagnostic and Clinical Research Unit, University of Cape Town Lung Institute, Cape Town, South Africa.
  • Ryan D; Woodbrook Medical Centre, Loughborough, UK ; Allergy and Respiratory Research Group, The University of Edinburgh, Edinburgh, UK.
  • Samolinski B; Department of Prevention of Environmental Hazards and Allergology, Medical University of Warsaw, Warsaw, Poland.
  • Schunemann HJ; Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON Canada.
  • Sheikh A; Allergy and Respiratory Research Group, Centre for Population Health Sciences, The University of Edinburgh Medical School, Edinburgh, UK.
  • Simons FE; Department of Pediatrics and Child Health, Department of Immunology, Faculty of Medicine, University of Manitoba, Winnipeg, MB Canada.
  • Stellato C; Division of Allergy and Clinical Immunology, University of Salerno, Salerno, Italy.
  • Todo-Bom A; Centre of Pneumology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
  • Tomazic PV; Department of ENT, Medical University of Graz, Graz, Austria.
  • Valiulis A; Clinic of Children's Diseases, Faculty of Medicine, Vilnius University, Vilnius, Lithuania ; Public Health Institute, Vilnius University, Vilnius, Lithuania ; European Academy of Paediatrics (EAP/UEMS-SP), Brussels, Belgium.
  • Valovirta E; Department of Lung Diseases and Clinical Allergology, University of Turku, Turku, Finland ; Allergy Clinic, Terveystalo, Turku, Finland.
  • Ventura MT; Unit of Geriatric Immunoallergology, University of Bari Medical School, Bari, Italy.
  • Wickman M; Sachs' Children and Youth Hospital, Södersjukhuset, Stockholm, Sweden ; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Clin Transl Allergy ; 6: 47, 2016.
Article em En | MEDLINE | ID: mdl-28050247
ABSTRACT
The Allergic Rhinitis and its Impact on Asthma (ARIA) initiative commenced during a World Health Organization workshop in 1999. The initial goals were (1) to propose a new allergic rhinitis classification, (2) to promote the concept of multi-morbidity in asthma and rhinitis and (3) to develop guidelines with all stakeholders that could be used globally for all countries and populations. ARIA-disseminated and implemented in over 70 countries globally-is now focusing on the implementation of emerging technologies for individualized and predictive medicine. MASK [MACVIA (Contre les Maladies Chroniques pour un Vieillissement Actif)-ARIA Sentinel NetworK] uses mobile technology to develop care pathways for the management of rhinitis and asthma by a multi-disciplinary group and by patients themselves. An app (Android and iOS) is available in 20 countries and 15 languages. It uses a visual analogue scale to assess symptom control and work productivity as well as a clinical decision support system. It is associated with an inter-operable tablet for physicians and other health care professionals. The scaling up strategy uses the recommendations of the European Innovation Partnership on Active and Healthy Ageing. The aim of the novel ARIA approach is to provide an active and healthy life to rhinitis sufferers, whatever their age, sex or socio-economic status, in order to reduce health and social inequalities incurred by the disease.
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Clin Transl Allergy Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Clin Transl Allergy Ano de publicação: 2016 Tipo de documento: Article